In all five cases of UBP6-linked human cancers referred to above, it remains unclear whether the heterologous promoters cause overexpression of normal, full-length UBP6 protein, or whether there have been further mutations, deletions, or alternate splicing within USP6 to produce an altered, oncogenic UBP6 protein. Here, USP6 is linked to cancer.